Insights

North America expansion Exothera has recently launched an mRNA Ntensify platform and established a facility in Massachusetts, signaling a strategic push into the North American market that could benefit clients seeking local GMP capabilities and accelerated development timelines.

Clinical and commercial focus As a CDMO specializing in viral vectors and nucleic acids with capabilities spanning discovery to GMP manufacturing, Exothera offers end-to-end support for gene therapies, providing opportunities to partner on both early development and scale-up for commercial production.

High value partnerships Recent collaborations with NIH and Asgard Therapeutics demonstrate a track record of engaging with high-profile public and private entities for process development and manufacturing, signaling credibility and potential access channels for larger bio-pharma opportunities.

Technology driven efficiency Leveraging Univercells’ advanced manufacturing technologies and the Ntensify platform, Exothera positions itself to deliver cost-efficient, agile manufacturing solutions, appealing to clients seeking faster timelines and reduced material costs in viral vector production.

Growing scope and diversity With a broad client base and ongoing expansions into North America, Exothera can target a variety of stakeholders from biotechs to academic collaborations, expanding opportunities across vaccine, gene therapy, and intranasal vaccine programs.

Similar companies to Exothera

Exothera Tech Stack

Exothera uses 8 technology products and services including Google Ads, Power BI, Shopify, and more. Explore Exothera's tech stack below.

Media & News

Exothera's Email Address Formats

Exothera uses at least 2 email formats:
Exothera Email FormatsExamplePercentage
F.Last@exothera.worldJ.Doe@exothera.world
98%
First@exothera.worldJohn@exothera.world
2%

Frequently Asked Questions

What is Exothera's official website and social media links?

Minus sign iconPlus sign icon
Exothera's official website is exothera.world and has social profiles on LinkedIn.

How much revenue does Exothera generate?

Minus sign iconPlus sign icon
As of October 2026, Exothera's annual revenue is estimated to be $1M - $10M.

What is Exothera's SIC code and NAICS code?

Minus sign iconPlus sign icon
Exothera's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Exothera have currently?

Minus sign iconPlus sign icon
As of October 2026, Exothera has approximately 25 employees across 1 continents, including Europe. Key team members include Head Of E2e Solutions: B. D., Marketing Director: S. H. and Senior Development And Production Scientist: J. L. Explore Exothera's employee directory with LeadIQ.

What industry does Exothera belong to?

Minus sign iconPlus sign icon
Exothera operates in the Biotechnology Research industry.

What technology does Exothera use?

Minus sign iconPlus sign icon
Exothera's tech stack includes Google Ads, Power BI, Shopify, Mailchimp, Google Cloud, HubSpot, WP Engine and Adobe Creative Suite.

What is Exothera's email format?

Minus sign iconPlus sign icon
Exothera's email format typically follows the pattern of F.Last@exothera.world. Find more Exothera email formats with LeadIQ.
Exothera logo

Exothera

Biotechnology ResearchWallonia, Belgium11-50 Employees

Exothera is a contract research, development, and manufacturing organization focused on viral vector and nucleic acid production. As part of the Univercells group, it leverages bioprocessing expertise to support process development and GMP clinical and commercial production. Based in Jumet, Wallonia, Belgium, the company delivers discovery and development services to accelerate manufacturing readiness for gene therapies.

Recent developments include collaborations with the NIH on an intranasal vaccine manufacturing program and a partnership with Asgard Therapeutics for process development through early clinical phases. The firm has also expanded its footprint to North America with a site in Andover, Massachusetts, and has prior collaborations with IDT Biologika on viral vector vaccine production.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $1M - $10M

    Exothera's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.